Back to top

Image: Bigstock

New Strong Buy Stocks for November 13th

Read MoreHide Full Article

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

Enova International (ENVA - Free Report) : This financial technology and analytics company that offers consumer and small business loans and financing has seen the Zacks Consensus Estimate for its current year earnings increasing 2.8% over the last 60 days.

Enova International, Inc. Price and Consensus

NRG Energy, Inc. (NRG - Free Report) : This company which is engaged in production, selling and delivering electricity and related products and services has seen the Zacks Consensus Estimate for its current year earnings increasing 8.4% over the last 60 days.

NRG Energy, Inc. Price and Consensus

USANA Health Sciences, Inc. (USNA - Free Report) : This developer and manufacturer of nutritional and personal car products used to reduce risks related to chronic degenerative disease has seen the Zacks Consensus Estimate for its current year earnings increasing 5.6% over the last 60 days.

USANA Health Sciences, Inc. Price and Consensus

Synaptics Incorporated (SYNA - Free Report) : This developer of human interface solutions has seen the Zacks Consensus Estimate for its current year earnings increasing 6.9% over the last 60 days.

Synaptics Incorporated Price and Consensus

Kemper Corporation (KMPR - Free Report) : This provider of property and casualty, and life and health insurance services has seen the Zacks Consensus Estimate for its current year earnings increasing 9.7% over the last 60 days.

Kemper Corporation Price and Consensus

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>